Health AI Advisory
by Dr. Amir Lahav

Strategy, validation, and commercialization
for medical & consumer products

A a former Harvard Medical School professor and digital health leader at Pfizer, with broad experience across healthcare, life sciences, medical devices, and consumer health.

Helping companies turn visionary ideas into commercial success, from early strategy through market adoption and scale. Specialty areas include clinical validation, AI guardrails, and investment diligence for medical-grade and consumer health solutions.

“AI isn’t about brilliant algorithms,
it’s about basic ones used brilliantly.”
 The brilliance isn’t about algorithmic complexity — it’s about applying simple tools in non-obvious ways, and building human-AI teams around them with proper validation and guardrails.

• Investors
• Health Systems
• Regulators & Payers
• Pharma & Life Sciences
• Patient Advocacy Groups
• Startups & Emerging Tech
• Medtech, Healthtech & BigTech

​​​• Clinical & Scientific Validation
• Medical Devices & Patient Apps
• Wearables & Digital Endpoints
• AI Safety for Medical & Consumer
• Pharma Commercial & Clinical Trials
• Investment Strategy & Due Diligence
• Product Development & GTM Strategy

​​​• Scientific depth
​​​• Clinical expertise
• Honesty over diplomacy
​• Creative problem-solving
​​​ • Connections that open doors
​​​• Agility to see what others miss
​​​• Priority speaking at the DHAI Summit